70 likes | 219 Views
U.S. Multiple Sclerosis Therapies Markets Growing Number of Patients Drives Market.
E N D
U.S. Multiple Sclerosis Therapies MarketsGrowing Number of Patients Drives Market “Future growth is largely dependent upon successful penetration of the newly diagnosed patient market, as well as expansion into new markets such as primary progressive multiple sclerosis (PPMS) and the development of oral drug formulations.” Pharmaceutical Group Analyst Team Frost & Sullivan
Key Features • Frost & Sullivan provides: • Detailed insights into recent developments and trends • Drivers, restraints, challenges, and strategic recommendations • Analyst insights on ‘hot topics’ and emerging applications • in the multiple sclerosis therapiesmarket • Market sizing and competitive analysis • Market forecasts and opportunity analysis • Quarterly assessments • End user analysis within each report
What We Offer • Coverage: The United States • Proven methodology encompassing extensive primary and secondary data and research • Focused information and strategies that cover business and technology issues • Credible data and analysis highlighting industry dynamics • Winning strategies to help you create precise business plans
Who Will Benefit? Current Market Participants • Find out how you compare to the competition • Assess current and future drivers and restraints • Determine and exploit new market share opportunities New Entrants • Analyze challenges associated with the industry • Calculate time scales for strategy implementation • Position yourself to capitalize on the market’s unmet needs Investment Community • Analyze long-term strategies of companies • Determine which participants will outperform the competition • Assess attractiveness of investing in the market
Key Market Participants Acorda Therapeutics, Inc. Berlex Laboratories, Inc. Biogen, Inc. Cephalon, Inc. Corixa Corp. Immune Response Corp. Ivax Corp. Millennium Pharmaceuticals, Inc. NeoTherapeutics, Inc. Neurocrine Biosciences, Inc. Serono, Inc. Teva Neurosciences, Inc.
For More Information • Call toll free 877 GO FROST (877.463.7876) • Fax toll free 888.690.3329 • E-mail myfrost@frost.com • Visit www.frost.com